Position
Linscomb Wealth, Inc. in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$117K$579.37 → $491.58
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.33K | $772.3K | — | — | — | 0.0% |
| Q1 2026 | 2.27K | $1.12M | $491.58 | −$117K | $462.1K | 0.1% |